The applied value of public investments in biomedical research

Science

Volumn 356, Issue 6333, 2017, Pages 78-81

  Li, Danielle ^a   Azoulay, Pierre ^b,c   Sampat, Bhaven N ^c,d  

^a HARVARD BUSINESS SCHOOL   (United States)

^b MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^c NATIONAL BUREAU OF ECONOMIC RESEARCH   (United States)

^d Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACCOUNTABILITY; ECONOMIC ANALYSIS; INVESTMENT; RESEARCH WORK; THEORETICAL STUDY;

ARTICLE; ECONOMICS; HUMAN; INVESTMENT; MEDICAL RESEARCH; NATIONAL HEALTH ORGANIZATION; PATENT; PRIORITY JOURNAL; SCIENTIST; UNITED STATES; ANIMAL;

ANIMALS; BIOMEDICAL RESEARCH; HUMANS; INVESTMENTS; NATIONAL INSTITUTES OF HEALTH (U.S.); PATENTS AS TOPIC; UNITED STATES;

EID: 85016943288     PISSN: 00368075     EISSN: 10959203     Source Type: Journal    
DOI: 10.1126/science.aal0010     Document Type: Article

References (26)

1. V. Bush, Science: The Endless Frontier (U.S. Government Printing Office, Washington, DC, 1945).
2. H. Varmus, The Art and Politics of Science (W. W. Norton & Company, 2009).
3. H. Moses 3rd, E. R. Dorsey, D. H. M. Matheson, S. O. Thier, JAMA 294, 1333-1342 (2005).
4. M. A. Lemley, B. Sampat, Rev. Econ. Stat. 94, 817-827 (2012).
5. M. Roach, W. M. Cohen, Manage. Sci. 59, 504-525 (2013).
6. J. H. Comroe Jr., R. D. Dripps, Science 192, 105-111 (1976).
7. D. Stokes, Pasteur's Quadrant: Basic Science and Technological Innovation (Brookings Institution Press, Washington, DC, 1997).
8. J. H. Marburger 3rd, Science 308, 1087 (2005).
9. K. Pavitt, Res. Policy 20, 109-119 (1991).
10. D. Partha, P. A. David, Res. Policy 23, 487-521 (1994).
11. G. L. Westbrook, "Basic Research Considerations for NINDS: Analysis and Recommendations" (NIH, 2009); www.ninds.nih.gov/sites/default/files/basic-module-1.pdf.
12. L. E. Rosenberg, "Scientific Opportunities and Public Needs: Improving Priority Setting and Public Input at the National Institutes of Health" (Report of the Committee on the NIH Research Priority-Setting Process, Institute of Medicine, Washington, DC, 1998).
13. S. Fields, M. Johnston, Science 307, 1885-1886 (2005).
14. Brown (26) provides an illustration of this point in his case study of research on the tiny hermaphrodite worm Caenorhabditis elegans.
15. A. J. Stevens et al., N. Engl. J. Med. 364, 535-541 (2011).
16. M. J. Kalutkiewicz, R. L. Ehman, Nat. Biotechnol. 32, 536-537 (2014).
17. B. N. Sampat, F. R. Lichtenberg, Health Aff. (Millwood) 30, 332-339 (2011).
18. B. N. Sampat, H. A. Pincus, Clin. Transl. Sci. 8, 759-763 (2015).
19. F. Narin, K. S. Hamilton, D. Olivastro, Res. Policy 26, 317-330 (1997).
20. A. K. Rai, B. N. Sampat, Nat. Biotechnol. 30, 953-956 (2012).
21. C. A. Cotropia, M. A. Lemley, B. Sampat, Res. Policy 42, 844-854 (2013).
22. B. N. Sampat, J. Law Econ. 53, 399-416 (2010).
23. D. C. Mowery, B. N. Sampat, in Essays in Honor of Edwin Mansfield: The Economics of R&D, Innovation, and Technological Change, A. N. Link, F. M. Scherer, Eds. (Springer, New York, 2005), pp. 233-245.
24. C. Macilwain, Nature 465, 682-684 (2010).
25. M. Trajtenberg, R. M. Henderson, A. B. Jaffe, Econ. Innov. New Technol. 5, 19-50 (1997).
26. A. Brown, In the Beginning Was the Worm: Finding the Secrets of Life in a Tiny Hermaphrodite (Columbia Univ. Press, New York, 2003).